The abstract is read at the publisher; the summary is JClub's.
Predicted protein abundance linked to lung cancer in GWAS identifies 29 susceptibility proteins at an FDR, including eight replicated in independent lung tissue proteomics.
- Why it matters: Proteins can be drug targets, but susceptibility mechanisms are unclear; integrating genetics with lung tissue proteomics aims to pinpoint proteins tied to lung cancer risk.
- What they did: The team profiled proteomes and genomes in 200 non-neoplastic lung samples, built genetic models for protein abundance, tested associations in 55,174 cases and 1,294,174 controls, then used cross-dataset validation plus colocalization and summary-data-based Mendelian randomization.
- The result: Eight predicted proteins and six significant proteins were confirmed in independent data; DSP, IL18, and TYMP showed reproducible and potential causal evidence and are targeted by six FDA-approved or phase III drugs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.